TipRanks on MSN
Vertex Pharmaceuticals Advances Phase 3 Study on Suzetrigine for Diabetic Neuropathy Pain
Vertex Pharmaceuticals Inc. (($VRTX)) announced an update on their ongoing clinical study. Vertex Pharmaceuticals Inc. is conducting a Phase 3 ...
TipRanks on MSN
Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment
This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback